生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
COLO-320(RCB1193)
,
LoVo(RCB1639)
|
77042
|
Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
|
Cancer Sci |
2021-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MH7A(RCB1512)
|
72436
|
Enhancement of anti-inflammatory tendency by SB203580, p38alpha specific inhibitor, in human fibroblast-like synoviocyte cell line, MH7A.
|
Rheumatol Int |
2006-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
LM8(RCB1450)
|
69497
|
The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression.
|
Anticancer Res |
2021-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Hep G2(RCB1648)
,
HuH-7(RCB1942)
|
67552
|
Effects of Pyrrole-Imidazole Polyamides Targeting Human TGF-β1 on the Malignant Phenotypes of Liver Cancer Cells.
|
Molecules |
2020-6-23 |
Pubmed
Full text
|
ヒト・動物細胞
|
LM8(RCB1450)
|
67431
|
Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
|
Toxicol Appl Pharmacol |
2012-3-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
Lu99(RCB1900)
|
67417
|
Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
|
J Med Chem |
2015-2-26 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuH-7(RCB1366)
|
67285
|
Targeting cap-dependent translation to inhibit Chikungunya virus replication: selectivity of p38 MAPK inhibitors to virus-infected cells due to autophagy-mediated down regulation of phospho-ERK.
|
J Gen Virol |
2021-7-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Hep G2(RCB1648)
|
64027
|
Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines.
|
Oncol Rep |
2011-11-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
NIH/3T3(RCB2767)
|
63530
|
Zoledronic acid suppresses transforming growth factor-β-induced fibrogenesis by human gingival fibroblasts.
|
Int J Mol Med |
2016-7-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
32Dcl3
|
61656
|
Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
|
Genes Chromosomes Cancer |
2016-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
TGBC1TKB(RCB1129)
,
TGBC24TKB(RCB1196)
|
61441
|
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
|
Cancer Sci |
2013-5-1 |
Pubmed
Full text
|
実験動物マウス
|
RBRC01361
|
57694
|
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia.
|
Nat Commun |
2019-10-25 |
Pubmed
Full text
|
ヒト・動物細胞
|
Hep G2
|
55993
|
Acceleration of murine hepatocyte proliferation by imazalil through the activation of nuclear receptor PXR.
|
J Toxicol Sci |
2018-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MDCK(RCB0995)
|
54087
|
Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.
|
Vet J |
2018-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HCT116(RCB2979)
|
52404
|
SKL2001 suppresses colon cancer spheroid growth through regulation of the E-cadherin/β-Catenin complex.
|
Biochem Biophys Res Commun |
2017-11-25 |
Pubmed
Full text
|
ヒト・動物細胞
|
Li-7(RCB1941)
,
Hep G2(RCB1648)
,
T2(RCB1932)
,
K562
|
51643
|
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
|
Int J Oncol |
2016-5-1 |
Pubmed
Full text
|
ゼブラフィッシュ
|
Tg(6xTcf/LefBS-miniP:d2EGFP)
|
49679
|
Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer.
|
Proc Natl Acad Sci U S A |
2016-8-16 |
Pubmed
Full text
|
病原微生物
|
|
46842
|
Candida glabrata drug:H+ antiporter CgQdr2 confers imidazole drug resistance, being activated by transcription factor CgPdr1.
|
Antimicrob Agents Chemother |
2013-7-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
|
44698
|
Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
JHUEM-2(RCB1551)
|
44564
|
The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors.
|
Neoplasia |
2013-8-1 |
Pubmed
Full text
|